Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes

Archives of Disease in Childhood

Volumn 95, Issue 2, 2010, Pages 119-124

  Marcovecchio, M Loredana ^a   Dalton, R Neil ^b   Turner, Charles ^b   Prevost, A Toby ^c   Widmer, Barry ^a   Amin, Rakesh ^a   Dunger, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLARGININASE; HEMOGLOBIN A1C; INSULIN; CREATININE;

ADOLESCENT; ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PLASMA CLEARANCE; PRIORITY JOURNAL; SEX RATIO; ULTRAFILTRATION; CREATININE BLOOD LEVEL; KIDNEY FUNCTION;

ADOLESCENT; AGE OF ONSET; ALBUMINURIA; ARGININE; BIOLOGICAL MARKERS; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; ENGLAND; EPIDEMIOLOGIC METHODS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; PROGNOSIS;

EID: 77149122397     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2009.158394     Document Type: Article

References (36)

1. Rossing P, Hougaard P, Borch-Johnsen K, et al. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996;313:779-84.
2. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
3. Almdal T, Nörgaard K, Feldt-Rasmussen B, et al. The predictive value of microalbuminuria in IDDM. A five-year follow-up study. Diabetes Care 1994;17:120-5.
4. Christiansen JS, Gammelgaard J, Frandsen M, et al. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 1981;20:451- 6.
5. Mogensen CE, Andersen MJ. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973;22:706- 12.
6. Amin R, Turner C, van Aken S, et al. The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int 2005;68:1740-9.
7. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy - an 8-year prospective study. Kidney Int 1992;41:822-8.
8. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-83.
9. Hogg RJ, Furth S, Lemley KV, et al; National Kidney Foundation's Kidney Disease Outcomes Quality Initiative. National Kidney Foundation's Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 2003;111:1416-21.
10. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38:1933-53.
11. Gowans EM, Fraser CG. Biological variation of serum and urine creatinine and creatinine clearance: ramifications for interpretation of results and patient care. Ann Clin Biochem 1988;25(Pt 3):259-63.
12. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571-90.
13. Böger RH. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann Med 2006;38:126-36.
14. Kielstein JT, Salpeter SR, Bode-Boeger SM, et al. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - a meta-analysis. Nephrol Dial Transplant 2006;21:2446-51.
15. Dalton R, Booth C, Mallard B, et al. SDMA is an endogenous marker of glomerular filtration rate. J Am Soc Nephrol 2005:16(Abstract).
16. Schultz CJ, Konopelska-Bahu T, Dalton RN, et al. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 1999;22:495-502.
17. Florijn KW, Barendregt JN, Lentjes EG, et al. Glomerular filtration rate measurement by 'single-shot' injection of inulin. Kidney Int 1994;46:252-9.
18. Veall N, Gibbs GP. The accurate determination of tracer clearance rates and equilibrium distribution volumes from single injection plasma measurements and numerical analysis. In: Radionucleotides in Nephrology, Proceedings of the 5th Symposium. London, 1982:125-30.
19. Marcovecchio ML, Widmer B, Dunger DB, et al. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes. Clin Sci 2008;115:361-9.
20. Mattman A, Eintracht S, Mock T, et al. Estimating pediatric glomerular filtration rates in the era of chronic kidney disease staging. J Am Soc Nephrol 2006;17:487-96.
21. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
22. Goldstein H, Healy MJ, Rasbash J. Multilevel time series models with applications to repeated measures data. Stat Med 1994;13:1643-55.
23. Tarnow L, Hovind P, Teerlink T, et al. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes. Diabetes Care 2004;27:765-9.
24. Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 2004;24:1023-30.
25. Marescau B, Nagels G, Possemiers I, et al. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency. Metab Clin Exp 1997;46:1024-31.
26. Kielstein JT, Böger RH, Bode-Böger SM, et al. Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol 2002;13:170-6.
27. Lamb EJ, Wood J, Stowe HJ, et al. Susceptibility of glomerular filtration rate estimations to variations in creatinine methodology: a study in older patients. Ann Clin Biochem 2005;42:11-18.
28. Preiss DJ, Godber IM, Lamb EJ, et al. The influence of a cooked-meat meal on estimated glomerular filtration rate. Ann Clin Biochem 2007;44:35-42.
29. Guignard JP, Santos F, Estimation of glomerular filtration rate in clinical practice with different markers. In Avner ED, Harmon W, Niaudet P: Pediatric nephrology. 5th Edition, LWW, Philadelphia 2004.
30. Marliss EB, Chevalier S, Gougeon R, et al. Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover. Diabetologia 2006;49:351-9.
31. Siroen MP, van Leeuwen PA, Nijveldt RJ, et al. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 2005;33:504-10.
32. Lücke T, Kanzelmeyer N, Kemper MJ, et al. Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age. Clin Chem Lab Med 2007;45:1525-30.
33. Amin R, Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008;336:697-701.
34. Dalton R, Turner C. Clinical applications of mass spectrometry. In: Ashcroft AE, Brenton G, Monaghan JJ, eds. Advances in mass spectrometry. Amsterdam: Elsevier, 2004:315-22.
35. Bode-Böger SM, Scalera F, Kielstein JT, et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 2006;17:1128- 34.
36. Kiechl S, Lee T, Santer P, et al. Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis 2009;205:261-5.